The IL-6 signalling is important in the pathogenesis of several autoimmune and chronic inflammatory diseases31 and antibody-based drugs are used to target the IL-6 receptor in patients with RA in order to dampen the inflammatory response32. The gene discussed is IL6; the disease is rheumatoid arthritis.